Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

被引：0

|

作者：

Haider, Karim S.

Haider, Ahmad

Saad, Farid

机构：

来源：

DIABETES | 2019年 / 68卷

关键词：

D O I：

10.2337/db19-1123-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1123-P

引用

收藏

页数：2

相关论文

共 50 条

[21] LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS SUSTAINABLY IMPROVES ERECTILE FUNCTION AND METABOLIC CONTROL IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM)
Haider, Ahmad
Haider, Karim Sultan
Doros, Gheorghe
Traish, Abdulmaged
JOURNAL OF UROLOGY, 2015, 193 (04): : E903 - E903
[22] Less mortality and less Major Adverse Cardiovascular Events (MACE) under long-term Testosterone Therapy (TTh): 15-year data from a prospective controlled registry study
Al-Qudimat, A.
Al-Zuobi, R.
Aboumarzouk, O. M.
Saad, F.
Haider, K.
Alansari, A.
Yassin, A.
Alkadhi, S.
EUROPEAN UROLOGY, 2021, 79 : S731 - S731
[23] LESS MORTALITY AND LESS MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) UNDER LONG-TERM TESTOSTERONE THERAPY (TTH): 15-YEAR DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY
Al-Qudimat, Ahmad
Alwani, Mustafa
Al-Zoubi, Raed M.
Al-Rumaihi, Khalid
Talib, Raidh
Haider, Karim
Saad, Farid
JOURNAL OF UROLOGY, 2021, 206 : E992 - E993
[24] IMPROVEMENT AND STABILIZATION OF ERECTILE FUNCTION, ANTHROPOMETRIC AND METABOLIC PARAMETERS IN HYPOGONADAL MEN WITH TYPE 2 DIABETES MELLITUS (T2DM) ON LONG-TERM TREATMENT WITH TESTOSTERONE UNDECANOATE INJECTIONS
Saad, F.
Doros, G.
Haider, A.
Traish, A.
JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 245 - 246
[25] GLYCEMIC CONTROL AND INSULIN RESISTANCE IN HYPOGONADAL MEN WITH TYPE 2 DIABETES (T2DM) WITH LONG-TERM TESTOSTERONE THERAPY (TTH): 15-YEAR DATA FROM A PROSPECTIVE CONTROLLED REGISTRY STUDY
Aboumarzouk, Omar
Al-Qudimat, Ahmad
Alwani, Mustafa
Al-Rumaihi, Khalid
Talib, Raidh
Haider, Karim
Saad, Farid
Al-Zoub, Raed M.
JOURNAL OF UROLOGY, 2021, 206 : E477 - E478
[26] Treatment with Testosterone Undecanoate Injections (TU) Results in Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Urological Practice
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2021, 70
[27] Contribution of type 2 diabetes to major adverse cardiovascular events (MACE) in a long-term observational study with different stages of atherosclerosis
Mader, Arthur
Haeberli, Dario
Larcher, Barbara
Dopheide, Joern F.
Saely, Christoph H.
Heinzle, Christine F.
Amann, Peter
Schindewolf, Marc
Festa, Andreas
Drexel, Heinz
SCIENTIFIC REPORTS, 2025, 15 (01):
[28] Effects of Long-term Testosterone Treatment on the Lipid Pattern in hypogonadal Men with Type 2 Diabetes (T2D) in a urological Registry Study
Saad, Farid
Haider, Karim Sultan
Haider, Ahmad
WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 217 - 217
[29] Lipid Profile in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: Update of Real-World Registry Data
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2020, 69
[30] Effects of Treatment with Testosterone Undecanoate Injections (TU) on Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus (T2DM) Compared with an Untreated Control Group: Real-World Data
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2020, 69

← 1 2 3 4 5 →